Annual Drug Patent Expirations for EPCLUSA
Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are fifteen patents protecting this drug.
Drug patent litigation for EPCLUSA.
This drug has twenty-five patent family members in twenty countries.
The generic ingredient in EPCLUSA is sofosbuvir; velpatasvir. One supplier is listed for this compound. Additional details are available on the sofosbuvir; velpatasvir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
